Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.

Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.

Kayvon Modjarrad, M.D., Ph.D., director of Emerging Infectious Disease Threats at the Walter Reed Army Institute of Research in Silver Spring, Maryland, will be the keynote speaker Sept. 25 at a forum entitled “Global Health at Vanderbilt.”

Researchers in the Vanderbilt Institute for Global Health are testing whether a unique “couples-centered” intervention developed in the southern African nation of Mozambique can reduce mother-to-child transmission of HIV.

This week Douglas Heimburger, M.D., M.S., professor of Medicine at Vanderbilt, joined a growing chorus calling for preservation of the Fogarty International Center of the National Institutes of Health (NIH).

The health of people around the world depends to a large extent on the ability of the global health community to predict what challenges must be met in the future.

Since July, investigators in the Vanderbilt Tuberculosis Center have been awarded research grants totaling $5 million.